Cargando…

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes

Background: Hepatocellular carcinoma (HCC) is very common globally prevalent cancer. Due to its poor clinical prognosis, increasing the diagnostic rate of HCC is urgently needed. Herein, we validate discovered metabolomic biomarkers to distinguish Hepatitis B virus (HBV)-related HCC, including alpha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jianping, Zhao, Yanan, Qin, Ling, Li, Kang, Zhao, Yan, Sun, Huanqin, Zhang, Ting, Zhang, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803550/ https://www.ncbi.nlm.nih.gov/pubmed/31681602 http://dx.doi.org/10.3389/fonc.2019.01069

Ejemplares similares

Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib
por: Liu, Bo, et al.
Publicado: (2022)

Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma
por: Zhang, Aiying, et al.
Publicado: (2016)

Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma
por: Cao, Xinyi, et al.
Publicado: (2021)

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)

Reappraisal of the diagnostic value of alpha‐fetoprotein for surveillance of HBV‐related hepatocellular carcinoma in the era of antiviral therapy
por: Qian, Xiangjun, et al.
Publicado: (2020)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma
por: Zhang, Zhiguo, et al.
Publicado: (2015)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha‐fetoprotein assessment
por: Tajiri, Hitoshi, et al.
Publicado: (2016)

Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma
por: Yang, Chengkai, et al.
Publicado: (2023)

A CpG Methylation Signature as a Potential Marker for Early Diagnosis of Hepatocellular Carcinoma From HBV-Related Liver Disease Using Multiplex Bisulfite Sequencing
por: Li, Kang, et al.
Publicado: (2021)

Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018)

Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma
por: Song, Ting, et al.
Publicado: (2019)

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice
por: Ma, Chenyu, et al.
Publicado: (2023)

TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma
por: Shen, Suqin, et al.
Publicado: (2020)

A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes
por: Zhang, Qiyao, et al.
Publicado: (2020)

Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China
por: Hou, Gang, et al.
Publicado: (2023)

The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy
por: Xu, Ying, et al.
Publicado: (2022)

Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
por: Wu, Guoyi, et al.
Publicado: (2019)

Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
por: Lin, Bo, et al.
Publicado: (2021)

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients
por: Zhang, Wei-bin, et al.
Publicado: (2022)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
por: Hanif, Hira, et al.
Publicado: (2022)

The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022)

Association of alpha-fetoprotein and metastasis for small hepatocellular carcinoma: A propensity-matched analysis
por: Wang, Yu-Qi, et al.
Publicado: (2022)

The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract—A Single-Center Retrospective Study
por: Kong, Xiang-Xing, et al.
Publicado: (2021)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
por: Wang, Yurong, et al.
Publicado: (2018)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV-associated hepatocellular carcinoma
por: Zhao, Yanan, et al.
Publicado: (2020)

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
por: Xu, Ye, et al.
Publicado: (2021)

CD133 expression and α-fetoprotein levels define novel prognostic subtypes of HBV-associated hepatocellular carcinoma: A long-term follow-up analysis
por: Dai, Xiao-Meng, et al.
Publicado: (2018)

Blood Serum Alpha Fetoprotein Enhancer Binding Protein, a Tumor Suppressor, Decreases in Chronic HBV Hepatitis Patients as Hepatocellular Cancer Appears
por: Riggins, James N., et al.
Publicado: (2010)

HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature
por: Wang, Caixia, et al.
Publicado: (2016)

Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)–Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma
por: Ren, Ao, et al.
Publicado: (2020)

Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis
por: Sun, Tingting, et al.
Publicado: (2018)

Elevated Serum Alpha-Fetoprotein Is a Significant Prognostic Factor for Patients with Gastric Cancer: Results Based on a Large-Scale Retrospective Study
por: Zhan, Zhouwei, et al.
Publicado: (2022)

Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma
por: Bachtiar, Indra, et al.
Publicado: (2010)

Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
por: Hu, Jian, et al.
Publicado: (2018)

Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
por: Ruch, Brianna, et al.
Publicado: (2022)

Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma
por: Schraiber, Luciana dos Santos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jslg9dagn0q5pb476lm02o6qd5